Infrared Digital Thermography is a sophisticated technology which is used as a screening tool for the early detection of breast cancer. The procedure is FDA approved and unlike mammography and some other imaging modalities. Infrared digital thermography does not require radiation, compression, contact, or intravenous injection. As such, thermography is a very comfortable procedure, which poses absolutely NO health risks to the patient. The use of Digital Infrared Imaging is based on the principle that metabolic activity and vascular circulation in both pre-cancerous tissue and the area surrounding a developing breast cancer is almost always higher than in normal breast tissue.

In an ever-increasing need for nutrients, cancerous tumors increase circulation to their cells by holding open existing blood vessels, opening dormant vessels, and creating new ones (neoangiogenesis).  This process frequently results in an increase in regional surface temperatures of the breast. Meditherm Digital thermography uses ultra-sensitive medical infrared cameras and sophisticated computers to detect, analyze, and produce high-resolution diagnostic images of these temperature variations. Because of digital infrared thermography is so extremely sensitive, these temperature variations may be among the earliest signs of breast cancer and/or a pre-cancerous state of the breast.  Current methods used to detect breast cancer depend primarily on the combination of both physical examination and mammography. While this approach has become the mainstay of early breast cancer detection, mortality from this disease has gone relatively unchanged for 40 years. Since the absolute prevention of breast cancer has not become a reality as of yet, efforts must be directed at detecting breast cancer at its earliest stage. As such, the addition of Digital Infrared Imaging (Breast Thermography) to the frontline of early breast cancer detection brings a great deal of good news for women.